| abstract |
The present invention provides improved methods, kits, and pharmaceutical compositions for increasing white blood cell survival following chemotherapy, and mobilizing hematopoietic progenitor cells from bone marrow into peripheral blood, comprising the administration of an effective amount of angiotensinosin, angiotensin I (AI) , AI analogues, AI fragments and analogues thereof, angiotensin II (AII), AII analogues, All fragments or analogues thereof or AII AT2 type 2 receptor agonists. |